Superworth

AtriCure price to free cash flow ATRC

Market value divided by free cash flow over the last twelve months, since 2025.

Today, Nov 2, 2026
57.3×
Peer median
24.8×

AtriCure's price to free cash flow is 57.3× as of Nov 2, 2026.

The median for 10 medical instruments and supplies stocks of a similar size is 24.8×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far57.3×24.8×62.5×
202560.8×48.3×153×

Against its peers

Companies in Medical - Instruments & Supplies nearest AtriCure's size, closest first, today.

CompanyPrice to free cash flow
ATRCAtriCure57.3×
WRBYWarby Parker136×
NVSTEnvista16.0×
ICUIICU Medical26.6×
UFPTUFP Technologiesn/m
BMIBadger Meter31.6×
INSPInspire Medical Systems16.6×
VNTVontier12.9×
LMATLemaitre Vascular25.2×
MMSIMerit Medical Systems24.8×
HAEHaemonetics18.8×
Peer median24.8×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on AtriCure

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.